Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor
Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor
Recruiting · NCT05905887 · Registry updated 2026-04-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, gastrointestinal stromal tumor, neoplasm | Recruiting | Phase 2 | 2026-04-07 | NCT05905887 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Asan Medical Center | 114 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center, University of Ulsan College of Medicine | Seoul | South Korea | 4 |